CTOs on the Move

MJS BioLynx

www.biolynx.ca

 
MJS BioLynx Inc. is a Brockville, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million
  • www.biolynx.ca
  • PO Bag 1150 300 Laurier Blvd
    Brockville, ON CAN K6V 5W1
  • Phone: 613.498.2126

Executives

Name Title Contact Details

Similar Companies

Sightpath Medical

Sightpath Medical is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nemcomed

Nemcomed is a Hicksville, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hill-Rom

In a rapidly changing industry, caregivers remain the constant. Every day they demonstrate their passion for helping people despite unprecedented pressure to increase access and quality of care with the same or fewer resources. Hillrom is driven by patient-centered care. Everything we do, and all our products and technologies, are designed to enhance outcomes for patients and caregivers. It starts with cutting through complexity and focusing on the human side of healthcare. By continuously advancing and integrating our solutions, we enable clinicians to be vitally connected to their patients by delivering timely data and actionable insights. That means more accurate diagnoses, earlier intervention and faster recovery times. Our innovations put more heart in healthcare. Through more intelligent—and more connected—solutions, we help simplify routine workflows and communication, enabling care teams to focus on their passion—helping patients get better sooner. And we continuously raise the bar on quality and safety, building upon our legacy of trust with providers around the world. As healthcare continues to evolve, we`re here to support the people at the heart of it. Hillrom. Advancing Connected Care™.

JenaValve

JenaValve Technology, Inc., based in Irvine, California and Munich, Germany develops, manufactures and markets transcatheter aortic valve implantation (TAVI) systems to treat patients suffering from aortic valve disease. The Company’s transapical TAVI system is CE marked and currently marketed in Europe and other markets worldwide and its new transfemoral TAVI system is currently undergoing clinical evaluation in Europe with a view toward achieving CE Mark in 2015. JenaValve is backed by world-class U.S., European and Asian investors, including Atlas Venture, Edmond de Rothschild Investment Partners, GIMV, NeoMed Management, Legend Capital, VI Partners, Sunstone Capital, Omega Funds, Biovest and Valiance Advisors.

Eugene

Eugene is a Eugene, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.